Tuberculosis News: Breaking Tuberculosis News, Comments and Articles. - Page: 5

Global Fund concludes 2-day conference in Brussels

In Brussels on Wednesday, "the Global Fund to Fight AIDS, Tuberculosis and Malaria concluded a two-day conference where it tried to make the case for the $15 billion it aims to raise in a replenishment meeting late 2013," Devex reports.

Otsuka's New Drug Application for Tolvaptan, the Investigational Compound for Autosomal Dominant Polycystic Kidney Disease (ADPKD), Accepted for Review by the US Food and Drug Administration (FDA)

Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has accepted for priority review the company's new drug application (NDA) for the potential use of tolvaptan for the treatment of autosomal dominant polycystic kidney disease (ADPKD). Phase III clinical trial results that form the basis of the regulatory filing...

Researchers unravel dual role of tumor necrosis factor in TB

Tumor necrosis factor - normally an infection-fighting substance produced by the body- can actually heighten susceptibility to tuberculosis if its levels are too high.

Pitt Team Gets $5 Million NIH Grant To Make Vaccine Component That Stimulates TB-Fighting T-Cells

Researchers at the University of Pittsburgh School of Medicine have received a $5 million federal grant to develop a vaccine ingredient that can generate the type of immune response needed to protect against tuberculosis (TB) infection. Vaccines are...

$15B commitment to Global Fund would change the course of history

On Monday "in Brussels, the Global Fund to Fight AIDS, Tuberculosis and Malaria announced an appeal to government and private sector donors for $15 billion for the next three years," Joyce Banda, president of the Republic of Malawi, writes in the Huf...

Cell-destroyer that fights and promotes TB reveals what's behind its split identity

(University of Washington) TB can be a disease not only of failed immunity but also of excessive immune response. Tumor necrosis factor -- normally an infection-fighting substance produced by the body -- can actually heighten susceptibility to tuberc...

UNDP scales up focus on human rights and coordination in AIDS, TB and Malaria responses

The Global Fund to Fight AIDS, Tuberculosis and Malaria recently launched a New Funding Model aimed at increasing strategic investments, achieving greater impact and engaging implementers and partners more effectively in responding to HIV, TB and malaria.This new model provides an opportunity to prioritise human rights principles in future programmes. It also creates an opening for countries to r...

Interaction global health briefing provides recommendations to congress, administration

"If the United States does not follow through on global health commitments, there could be a reversal or stagnation of recent gains in reducing maternal deaths and incidences of tuberculosis, malaria, HIV and other diseases in developing countries, w...

Natural versus Synthetic Chemicals Is a Gray Matter

We consumers are bombarded with advertisements for natural and organic products. There are websites and news stories beyond counting dedicated to sharing the following message: "man-made is bad and natural is good". The growing popularity of this bel...

Continued support of Global Fund is worthy investment

Writing in the Huffington Post's "The Big Push" blog, Bill Gates, co-chair of the Bill & Melinda Gates Foundation, examines why the Global Fund to Fight AIDS, Tuberculosis and Malaria is a good investment.

Global Fund aims to raise $15B to fight infectious diseases in 2014-2016 period

"The Global Fund to Fight AIDS, Tuberculosis and Malaria has set the target of raising $15 billion to help countries fight the three infectious diseases in the 2014-2016 period, its Executive Director Mark Dybul said ... on Monday," Xinhua reports.

Anacor signs research agreement to discover drug candidates to treat neglected diseases

Anacor Pharmaceuticals today announced that it has signed a research agreement with the Bill & Melinda Gates Foundation (the Gates Foundation) to discover drug candidates intended to treat two filarial worm diseases (onchocerciasis, or river blindnes...

Expert: API Shortage for TB Treatments Causing Serious Concern in US

Ongoing shortages of the API isoniazid are forcing US state health departments to ration TB (tuberculosis) drugs and - for some patients - forego treatment altogether, a Johns Hopkins University expert told us.

Japanese public-private fund debuts

The Global Health Innovative Technology (GHIT) Fund debuted on Monday to advance R&D for therapeutics, vaccines and diagnostics for infectious diseases in the developing world. The public-private partnership was established by the Japanese government...

Anacor receiving up to $23M from Gates Foundation

Anacor Pharmaceuticals Inc. (NASDAQ:ANAC) will receive up to $17.7 million from the Bill & Melinda Gates Foundation to discover compounds to treat onchocerciasis, lymphatic filariasis and tuberculosis (TB). The foundation also purchased 809,061 Anaco...

Incentives for developing new antibiotics or antimicrobial strategies

Neonatal mortality approaches 50% in parts of Norway, cholera and typhoid fever force families to abandon their homes, parts of cities are quarantined. Tuberculosis mortality is 400/100 000 and 50%...

Participation in "Global Health Innovative Technology Fund (GHIT Fund)"

TOKYO, April 8, 2013 - Astellas Pharma Inc. (“Astellas”; Tokyo:4503; President and CEO: Yoshihiko Hatanaka) today announced that Astellas participated in the Global Health Innovative Technology Fund (GHIT Fund), the first public-private...

$87 bn needed to fight AIDS, TB, malaria: report

The fight against HIV AIDS, tuberculosis and malaria will cost some $87 billion (67 billion euros) between 2014-16 if the three scourges are to be kept in check, a report showed Monday.

Anacor Pharmaceuticals Receives Significant Investment to Support Neglected Disease Research

Anacor Pharmaceuticals (NASDAQ:ANAC) today announced that it has signed a research agreement with the Bill & Melinda Gates Foundation (the Gates Foundation) to discover drug candidates intended to treat two filarial worm diseases (onchocerciasis, or river blindness, and lymphatic filariasis, commonly known as elephantiasis) and tuberculosis (TB). Addit...

Global health gains under threat

NGOs outline risk in briefing book for Congress WASHINGTON, April 8, 2013 /PRNewswire-USNewswire/ -- If the United States does not follow through on global health commitments, there could be a reversal or stagnation of recent gains in reducing maternal deaths and incidences of tuberculosis, malaria, HIV and other diseases in developing countries, warns a report published today, ent...

Pilot project for HIVAIDS drug management supported by PAHOWHO and the Global Fund may expand to other countries

Three Latin American countries - Guatemala, Honduras, and the Dominican Republic - are working to strengthen their management of drugs for the treatment of HIVAIDS, as part of a pilot project supported by the Pan American Health OrganizationWorld Hea...

Private firms form initiative to offer accurate and affordable TB tests

Patients are to have access to more affordable and more accurate tuberculosis (TB) tests through private healthcare in India than were previously available.Until now, TB tests endorsed by the World...

Medicaid Expansion Will Open Doors To Care for Ex-Convicts

Newly freed prisoners traditionally walk away from the penitentiary with a bus ticket and a few dollars in their pockets. Starting in January, many of the 650,000 inmates released from prison each year will be eligible for something else: health care by way of Medicaid, thanks to the Affordable Care Act. A sizeable portion of the nearly 5 million ex-offenders who are on parole or probation at any...

India Considers Requiring Anti-OTC Cautions On Antibiotics, TB Drugs

India's health ministry proposes requiring labels on antibiotics, tuberculosis and other drugs that can be habit-forming to caution users against taking over-the-counter medicines.

Pill-watching practice may not improve Tuberculosis treatment

NEW YORK (Reuters Health) - Tuberculosis patients who swallow their anti-tuberculosis pills under the watchful gaze of doctors fare just as well as patients trusted to self-medicate, according to a new analysis.